Skip to main content
ImmuneCited

Omega-3 Fatty Acids (EPA/DHA) لـ Autoimmune Conditions

B الأدلة تدعم ذلك تجربة عشوائية واحدة على الأقل، مع نتائج متسقة في معظمها.

The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dautoimmune\u002Dconditions'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.

Key Study Findings

Review
Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity.
Dose: None مقابل: None Outcome: rheumatoid arthritis disease activity modulation through diet التأثير: None None

المجتمع المدروس: patients with rheumatoid arthritis

Case Reports n=1
GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus.
Dose: None مقابل: None Outcome: GPIHBP1 autoantibody and LPL mass normalization التأثير: None None

المجتمع المدروس: 12-year-old girl with SLE and severe hypertriglyceridemia

Review
Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and …
Dose: None مقابل: None Outcome: Epigenetic and mitochondrial modulation in MS التأثير: None None

المجتمع المدروس: Multiple sclerosis patients (review)

Review
The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive …
Dose: None مقابل: None Outcome: RA risk and disease activity التأثير: None None

المجتمع المدروس: Patients with rheumatoid arthritis

Review
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Systematic Review
Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: Systematic review of nutraceuticals in rheumatoid arthritis

Key Statistics

10

الدراسات

25000

المشاركون

Positive

B

التقييم

Referenced Papers

BMJ (Clinical research … 2022 9 اقتباسات
Nederlands tijdschrift voor … 2022 1 اقتباسات
Microbiology and immunology 2020 8 اقتباسات
Current diabetes reports 2010 33 اقتباسات
Journal of the … 2010 11 اقتباسات
Current opinion in … 2005 26 اقتباسات
Current atherosclerosis reports 2004 464 اقتباسات
Journal of the … 2002 2016 اقتباسات
Biochemical Society transactions 1995 15 اقتباسات
World review of … 1994 8 اقتباسات
The American journal … 1991 2278 اقتباسات
Rheumatic diseases clinics … 1991 19 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
250-500 mg combined EPA/DHA/day
antiinflammatory:
1,000-3,000 mg combined EPA/DHA/day

الحد الأعلى: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive --
None -- Positive 1
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Neutral --

أفضل وقت للتناول: With meals

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Fishy aftertaste and burping
  • Gastrointestinal discomfort (nausea, diarrhea)
  • Increased bleeding risk at high doses
  • Potential LDL cholesterol increase at very high doses

التفاعلات المعروفة

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive blood pressure lowering)
  • Orlistat (may reduce omega-3 absorption)
  • Cyclosporine (may modify immunosuppressive effects)

الحد الأقصى المسموح به: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Omega-3 Fatty Acids (EPA/DHA) help with Autoimmune Conditions?
Based on 10 studies with 25,000 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (EPA/DHA) may support Autoimmune Conditions management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Autoimmune Conditions?
Studies have used various dosages. A commonly studied range is 250-500 mg combined EPA/DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Gastrointestinal discomfort (nausea, diarrhea), Increased bleeding risk at high doses, Potential LDL cholesterol increase at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Autoimmune Conditions?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 25,000 total participants. The overall direction of effect is positive.

مكونات أخرى لـ Autoimmune Conditions

Omega-3 Fatty Acids (EPA/DHA) لحالات أخرى

References

  1. [1] Sin-Ting Tiffany Lai et al.. Case Rep Endocrinol. 2026. GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus. doi:10.1155/crie/6673352 PubMed
  2. [2] Elena Deseatnicova et al.. Nutrients. 2026. Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity. doi:10.3390/nu18030517 PubMed
  3. [3] Ada Radu et al.. Inflammopharmacology. 2025. Naturally derived bioactive compounds as precision modulators of immune and inflammatory mechanisms in psoriatic conditions. doi:10.1007/s10787-024-01602-z PubMed
  4. [4] Marta Vomero et al.. Autoimmun Rev. 2025. Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives. doi:10.1016/j.autrev.2025.103896 PubMed
  5. [5] Ashwani et al.. Mol Neurobiol. 2025. Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and Current Clinical Trials. doi:10.1007/s12035-025-04868-8 PubMed
  6. [6] Camila Leiva-Castro et al.. Inflammopharmacology. 2025. Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions. doi:10.1007/s10787-025-01976-8 PubMed
  7. [7] Maria Polyzou et al.. Nutrients. 2025. The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive Review. doi:10.3390/nu17243826 PubMed
  8. [8] Konstantinos Gkiouras et al.. Crit Rev Food Sci Nutr. 2024. Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis' disease activity indicators: a systematic review and meta-analysis of randomized placebo-controlled … doi:10.1080/10408398.2022.2104210 PubMed
  9. [9] Kimsor Hong et al.. Autoimmun Rev. 2024. Association between Omega-3 fatty acids and autoimmune disease: Evidence from the umbrella review and Mendelian randomization analysis. doi:10.1016/j.autrev.2024.103651 PubMed
  10. [10] Savino Sciascia et al.. Nutrients. 2024. The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance-A Patient-Driven, Multistep-Approach Study. doi:10.3390/nu16234132 PubMed
  11. [11] R Poggioli et al.. Eur Rev Med Pharmacol Sci. 2023. Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in … doi:10.26355/eurrev_202308_33310 PubMed
  12. [12] Yanbin Dong et al.. Nutrients. 2022. Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL … doi:10.3390/nu14245307 PubMed
  13. [13] Karen H Costenbader. BMJ. 2022. Vitamin D and fish oil supplements and risk of autoimmune disease. doi:10.1136/bmj.o243 PubMed
  14. [14] Verônica Assalin Zorgetto-Pinheiro et al.. J Med Food. 2022. Omega-3 Fatty Acids and Balanced Gut Microbiota on Chronic Inflammatory Diseases: A Close Look at Ulcerative Colitis and Rheumatoid Arthritis … doi:10.1089/jmf.2021.0012 PubMed
  15. [15] E Lubberts. Ned Tijdschr Geneeskd. 2022. [Vitamin D like one of few prevention possibilities for autoimmune diseases?]. PubMed
  16. [16] Welayah Ali AlAmmar et al.. Nutr Neurosci. 2021. Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. doi:10.1080/1028415X.2019.1659560 PubMed
  17. [17] Mariana Rodrigues Davanso et al.. Clin Sci (Lond). 2021. Macrophage inflammatory state in Type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid. doi:10.1042/CS20201348 PubMed
  18. [18] Liu Ouyang et al.. Microbiol Immunol. 2020. Therapeutic effect of omega-3 fatty acids on T cell-mediated autoimmune diseases. doi:10.1111/1348-0421.12800 PubMed
  19. [19] Leila Chehade et al.. Curr Rheumatol Rev. 2019. Lifestyle Modification in Rheumatoid Arthritis: Dietary and Physical Activity Recommendations Based on Evidence. doi:10.2174/1573397115666190121135940 PubMed
  20. [20] Mohd Hanif Zulfakar et al.. FEBS Open Bio. 2016. In vivo response of GsdmA3(Dfl)/+ mice to topically applied fish oil - effects on cellular markers and macrophages. doi:10.1002/2211-5463.12095 PubMed
  21. [21] Emily C Somers et al.. Environ Health Perspect. 2015. Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the United States: NHANES. doi:10.1289/ehp.1408751 PubMed
  22. [22] Alan D Strickland. Med Hypotheses. 2014. Prevention of cerebral palsy, autism spectrum disorder, and attention deficit-hyperactivity disorder. doi:10.1016/j.mehy.2014.02.003 PubMed
  23. [23] Jill M Norris. Curr Diab Rep. 2010. Infant and childhood diet and type 1 diabetes risk: recent advances and prospects. doi:10.1007/s11892-010-0131-5 PubMed
  24. [24] Linda A Linday. J Am Coll Nutr. 2010. Cod liver oil, young children, and upper respiratory tract infections. doi:10.1080/07315724.2010.10719894 PubMed
  25. [25] Arunabh Bhattacharya et al.. J Am Coll Nutr. 2005. Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. doi:10.1080/07315724.2005.10719466 PubMed
  26. [26] Christopher A Jolly. Curr Opin Clin Nutr Metab Care. 2005. Diet manipulation and prevention of aging, cancer and autoimmune disease. doi:10.1097/01.mco.0000172577.56396.7a PubMed
  27. [27] Trevor A Mori et al.. Curr Atheroscler Rep. 2004. Omega-3 fatty acids and inflammation. doi:10.1007/s11883-004-0087-5 PubMed
  28. [28] Artemis P Simopoulos. J Am Coll Nutr. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. doi:10.1080/07315724.2002.10719248 PubMed
  29. [29] D A Troyer et al.. Age (Omaha). 1998. Effects of calorie restriction and ω-3 dietary fat on aging in short-and long-lived rodents. doi:10.1007/s11357-998-0026-4 PubMed
  30. [30] D R Robinson et al.. Biochem Soc Trans. 1995. Suppression of autoimmune disease by omega-3 fatty acids. doi:10.1042/bst0230287 PubMed
  31. [31] G Fernandes et al.. J Immunol. 1994. Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W … PubMed
  32. [32] D R Robinson et al.. World Rev Nutr Diet. 1994. Alleviation of autoimmune disease by omega 3 fatty acids. doi:10.1159/000424001 PubMed
  33. [33] A P Simopoulos. Am J Clin Nutr. 1991. Omega-3 fatty acids in health and disease and in growth and development. doi:10.1093/ajcn/54.3.438 PubMed
  34. [34] D R Robinson. Rheum Dis Clin North Am. 1991. Alleviation of autoimmune disease by dietary lipids containing omega-3 fatty acids. PubMed
  35. [35] G Fernandes et al.. Proc Soc Exp Biol Med. 1990. Modulation of gene expression in autoimmune disease and aging by food restriction and dietary lipids. doi:10.3181/00379727-193-42983 PubMed
  36. [36] N J Alexander et al.. Am J Pathol. 1987. The type of dietary fat affects the severity of autoimmune disease in NZB/NZW mice. PubMed

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.